Apoptosis: Future directions in cancer therapy

National Medical Journal of India

Volumn 13, Issue 2, 2000, Pages 71-78

  Ravi, D ^a   Panikkar, K R ^a   Krishnan Nair, M ^a   Radhakrishna Pillai, M ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; HUMAN; MITOCHONDRION; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOCHONDRIA; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034154873     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Bowen ID. Apoptosis or programmed cell death. Cell Biol International 1993;17: 365-80.
2. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev 1992;11:95-103.
3. Decaudin DM, Geley S, Hirsh T, Castedo M, Marchetti P, Macho A, et al. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 1997;57:62-7.
4. Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997;89: 1845-53.
5. Collins MKL, Perkins GR, Rodriguez-Tarduchy G, Nieto MA, Lopez-Rivas A. Growth factors as survival factors: Regulation of apoptosis. Bioessays 1994;16: 133-8.
6. Weil M, Jacobson MD, Coles HSR, Davies TJ, Gardner RL, Raff KD, et al. Constitutive expression of the machinery for programmed cell death. J Cell Biol 1996;133:1053-9.
7. Gottlieb RA, Nordberg J, Skowronski E, Babior BM. Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci 1996;93:654-8.
8. Mower DA Jr, Peckham DW, Illera VA, Fishbaugh JK, Stunz LL, Ashman RF. Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J Immunol 1994;152:4832-42.
9. Smulson ME, Pang D, Jung M, Dimtchev A, Chasovskikh S, Spoonde A, et al. Irreversible binding of poly (ADP) ribose polymerase cleavage products to DNA ends revealed by atomic force microscopy: Possible role in apoptosis. Cancer Res 1998;58:3495-8.
10. He J, Whitacre CM, Xue L, Berger NA, Oleinick NL. Protease activation and cleavage of poly (ADP-ribose) polymerase: An integral part of apoptosis in response to photodynamic treatment. Cancer Res 1998;58:940-6.
11. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH. Premature p34 cdc 2 activation required for apoptosis. Science 1994;263:1143-5.
12. Huang DC, O'Reilly LA, Strasser A, Cory S. The antiapoptosis function of bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 1997;16:4628-38.
13. Brady HJ, Gil-Gomez G, Kirberg J, Berns AJ. Bax alpha perturbs Tcell development and affects cell cycle entry of T cells. EMBO J 1996;15:6991-7001.
14. Sharma K, Shi Y. The yins and yangs of ceramide. Cell Res 1999;9:1-10.
15. Zamzami N, Susin SA, Marchetti P, HirschT, Gomez-Monterey I, Castedo M, et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996;183:1533-44.
16. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
17. Herdt BG, Houston MA, Anthony GM, Augenlicht LH. Mitochondrial membrane potential (delta psi (mt)) in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res 1998;58: 2869-75.
18. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP, and cytochrome C. Cell 1996;86:147-57.
19. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p55-induced apoptosis. Nature 1997;389:300-5.
20. Wyllie A. Apoptosis: Clues in the p53 murder mystery. Nature 1997;389:237-8.
21. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, et al. Mitochondrial permeability transition is a central co-ordinating event of apoptosis. J Exp Med 1996;184:1155-60.
22. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996;184: 1331-42.
23. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by bcl-2: Release of cytochrome C from mitochondria blocked. Science 1997;275: 1129-32.
24. Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997;57:1835-10.
25. Knudson CM, Korsmeyer SJ. bcl-2 and bax function independently to regulate cell death. Nat Genet 1997;16:358-63.
26. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997;139:1281-92.
27. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HLA, et al. Bax and adenine nucleotide translocator co-operate in the mitochondrial control of apoptosis. Science 1998;281:2027-31.
28. He H, Lam M, McCormick ST, Distelhorst CW. Maintenance of calcium homeostasis in the endoplasmic reticulum by bcl-2. J Cell Biol 1997;138:1219-28.
29. Jacobson MD. Apoptosis: bcl-2 related proteins get connected. Curr Biol 1997; 7:R277-R281.
30. Shimizu S, Narita M, Tsujimoto Y. bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VCAC. Nature 1999;399: 483-7.
31. Haimovitz-Friedman A, Kolesnick RN, Fuks Z. Modulation of the apoptotic response: Potential for improving the outcome in clinical radiotherapy. Semin Radiol Oncol 1996;6:273-83.
32. Thornberry NA, Lazebnik YL. Caspases: Enemies within. Science 1998;281: 1312-16.
33. Ashkenazi A, Dixit VM. Death receptors: Signalling and modulation.Science 1998; 281:1305-8.
34. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997;277:815-18.
35. Zanke BW, Lee C, Arab S, Tannock IF. Death of tumour cells after intricellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by bcl-2 expression or Interleukin 1β converting enzyme inhibition. Cancer Res 1998;58:2801-8.
36. Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon LI, et al. The stress activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV-irradiation or heat. Curr Biol 1996;6:606-13.
37. Liu X, Li P, Widlak P, Zou H, Luo X, Garrard WT, et al. The 40 kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci 1998;95:8461-6.
38. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species: Role of mitochondrial glutathione. J Biol Chem 1997;379: 11369-77.
39. de Muricia JM, Niedergang C, Turcco C, Ricoul M, Dutrillaux B, Mark M, et al. Requirement of poly (ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci 1997;94:7303-7.
40. Ding R, Smulson ME. Depletion of nuclear poly (ADP ribose) polymerase by antisense RNA expression: Influence on genomic stability, chromatin ogranisation and carcinogen cytotoxicity. Cancer Res 1994;54:4627-34.
41. Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 1996;135:1441-55.
42. Naito M, Nagashima K, Mashima T, Tsuruo T. Phosphatidylserine externalization is a downstream event of interleukin-1 -beta converting enzyme family protease activation during apoptosis. Blood 1997;89:2060-6.
43. Kondo T, Takeuchi K, Doi Y, Yonemura S, Nagata S, Tsukita SL, et al. ERM (Ezrin/ Radixin/Moesin) based molecular mechanism of microvillar breakdown at an early stage of apoptosis. J Cell Biol 1997;139:749-58.
44. Brancolini C, Lazarevic D, Rodrigues J, Schneider C. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage ofβ catenin. J Cell Biol 1997;139:759-71.
45. Mills JC, Stone NL, Erhardt J, Pittman RN. Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J Cell Biol 1998;140:627-36.
46. Caulin C, Salverse GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997;138: 1379-94.
47. Cheng EH-Y, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, et al. Conversion of bcl-2 to a bax-like death effector by caspases. Science 1997;278:1966-8.
48. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
49. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lone DP, et al. The role of p53 in spontaneous and radiation-induced apoptosis in gastrointestinal tract of normal and p53-deficient mice. Cancer Res 1994;54:614-17.
50. Pai SI, Wu GS, Ozoren N, Wu L, Jen J, Sidransky D, et al. Rare loss-of-function mutation of a death receptor gene in head and neck cancer. Cancer Res 1998;58: 3513-18.
51. Cascino I, Papoff-G, DeMaria R, Testi R, Ruberti G. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from fas-mediated apoptosis. J Immunol 1996;156:13-17.
52. O'Connell-J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counter attack: Fas-mediated T cell killing by colon cancer expressing Fas ligand.J Exp Med 1996;184: 1075-82.
53. Wu GS, Burns TF, McDonald ER, Jiang W, Meng R, Krantz ID, et al. Killer/DR5 is a DNA damage inducible p53 regulated death receptor gene. Nat Genet 1997;17: 141-3.
54. Sidransky D, Hollstein M. Clinical implications of the p53 gene. Annu Rev Med 1996;47:285-310.
55. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the bax gene in colon cancers of the microsatellite mutator phenotype. Science 1997;375:967-9.
56. Meijerink JP, Mensink EJ, Wang K, Sedlak TW, Sloetzes AW, de Witte T, et al. Hematopoietic malignancies demonstrate loss-of-function mutations of bax. Blood 1998;91:2991-7.
57. Gil-Gomez G, Berns A, Brady HJM. A link between cell cycle and cell death: Bax and bcl-2 modulate cdk2 activation during thymocyte apoptosis. EMBO J 1998;17: 7209-18.
58. Beg AA, Baltimore D. An essential role for NF kappa B in preventing TNFα-induced cell death. Science 1996;274:782-9.
59. Lotem J, Sachs L. Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds. Proc Natl Acad Sci 1998;95:4061-6.
60. Smyth MJ, Krasovaskis E, Sutton VR, Johnstone RW. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci 1998;95:7024-9.
61. Ngan BY, Chen Levy Z, Weiss LM, Warnke RD, Cleary M. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with t(14:18) chromosomal translocation. N Engl J Med 1988;318:1638-44.
62. Hakem R, Hakem A, Duncan GS, Henderrson JT, Woo M, Soengas MS, et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998;94: 339-52.
63. Siegel RM, Martin DA, Zheng L, Ng SY, Berlin J, Cohen J, et al. Death-effector filaments: Novel cytoplasmic structures that recruit caspases and trigger apoptosis. J Cell Biol 1998;141:1243-53.
64. Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GCE. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol 1998;140:637-45.
65. MacCorkle RA, Freeman KW, Spencer DM. Synthetic activation of caspases: Artificial death switches. Proc Natl Acad Sci USA 1998;95:3655-60.
66. Gupta P, Niehans GA, LeRoy SC, Gupta K, Marrison VA, Schultz C, et al. Fas ligand expression in the bone marrow in myeloplastic syndromes correlates with FAB subtype and anemia, and predicts survival. Leukemia 1999;13:44-53.